INDP

Indaptus Therapeutics Inc (NASDAQ:INDP) The company's 13D filing on Friday after hours showed that Michael J. Newman had reported a stake of 25.7% in the company. The filing came out later in the session, so I think the stock should see a nice bump when it opens for trade on Monday. With such a low float and an oversold chart, this could create an explosive situation. If INDP is not on your watchlist now is the time to add it.